{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:54:12Z","timestamp":1790132052474,"version":"4.0.1"},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-1399","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T22:13:22Z","timestamp":1515795202000},"page":"309-315","source":"Crossref","is-referenced-by-count":17,"title":["Type 2 Myocardial Infarction\u3000\u2015 An Evolving Entity \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Cian P.","family":"McCarthy","sequence":"first","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi Jr","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital"},{"name":"Baim Institute for Clinical Research, Cardiometabolic Trials"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna K.","family":"Gaggin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital"},{"name":"Baim Institute for Clinical Research, Cardiometabolic Trials"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Obraztsov VP, Strazhesko ND. The symptomatology and diagnosis of coronary thrombus.<i>In<\/i>: Vorobeva VA, Konchalovski MP, editors. Works of First Congress of Russian Therapists. Comradeship Typography of A.E. Mamontov, Moscow, 1910; 2: 26\u201343."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. <i>Circulation<\/i> 2007; 116: 2634\u20132653.","DOI":"10.1161\/CIRCULATIONAHA.107.187397"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. <i>Circulation<\/i> 2015; 131: 1796\u20131803.","DOI":"10.1161\/CIRCULATIONAHA.114.010270"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, et al. American College of Cardiology\/American Heart Association\/European Society of Cardiology\/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: Observations from the Tritomn-TIMI 38 trial (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). <i>Circulation<\/i> 2012; 125: 577\u2013583.","DOI":"10.1161\/CIRCULATIONAHA.111.041160"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly NP, et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. <i>Circulation<\/i> 2017; 135: 116\u2013127.","DOI":"10.1161\/CIRCULATIONAHA.116.023052"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Friedberg CK, Horn H. Acute myocardial infarction not due to coronary artery occlusion. <i>JAMA<\/i> 1939; 112: 1675\u20131679.","DOI":"10.1001\/jama.1939.02800170021007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of the joint European Society of Cardiology\/American College of Cardiology committee for the redefinition of myocardial infarction. <i>J Am Coll Cardiol<\/i> 2000; 36: 959\u2013969.","DOI":"10.1016\/S0735-1097(00)00804-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. <i>Circulation<\/i> 2012; 126: 2020\u20132035.","DOI":"10.1161\/CIR.0b013e31826e1058"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. <i>J Am Coll Cardiol<\/i> 2014; 64: e139\u2013e228.","DOI":"10.1161\/CIR.0000000000000134"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the european society of cardiology (ESC). <i>Eur Heart J<\/i> 2016; 37: 267\u2013315.","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, et al. Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction. <i>Am J Med<\/i> 2013; 126: 789\u2013797.","DOI":"10.1016\/j.amjmed.2013.02.029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saaby L, Poulsen TS, Diederichsen AC, Hosbond S, Larsen TB, Schmidt H, et al. Mortality rate in type 2 myocardial infarction: Observations from an unselected hospital cohort. <i>Am J Med<\/i> 2014; 127: 295\u2013302.","DOI":"10.1016\/j.amjmed.2013.12.020"},{"key":"13","unstructured":"13. Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply\/demand type 2 myocardial infarction: Should we be paying more attention? <i>J Am Coll Cardiol<\/i> 2014; 63: 2079\u20132087."},{"key":"14","unstructured":"14. White HD. Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as necrosis? <i>J Am Coll Cardiol<\/i> 2011; 57: 2406\u20132408."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. <i>Intensive Care Med<\/i> 2001; 27: 965\u2013969.","DOI":"10.1007\/s001340100920"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. <i>Clin Chem<\/i> 2000; 46: 650\u2013657.","DOI":"10.1093\/clinchem\/46.5.650"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: A prospective study. <i>Intensive Care Med<\/i> 2000; 26: 31\u201337.","DOI":"10.1007\/s001340050008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. <i>Chest<\/i> 2006; 129: 1349\u20131366.","DOI":"10.1378\/chest.129.5.1349"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krishnagopalan S, Kumar A, Parrillo JE. Myocardial dysfunction in the patient with sepsis. <i>Curr Opin Crit Care<\/i> 2002; 8: 376\u2013388.","DOI":"10.1097\/00075198-200210000-00003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Salive ME. Multimorbidity in older adults. <i>Epidemiol Rev<\/i> 2013; 35: 75\u201383.","DOI":"10.1093\/epirev\/mxs009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shah ASV, McAllister DA, Mills R, Lee KK, Churchhouse AMD, Fleming KM, et al. Sensitive troponin assay and the classification of myocardial infarction. <i>Am J Med<\/i> 2015; 128: 493\u2013501.e493.","DOI":"10.1016\/j.amjmed.2014.10.056"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Baron T, Hambraeus K, Sundstr\u00f6m J, Erlinge D, Jernberg T, Lindahl B. Type 2 myocardial infarction in clinical practice. <i>Heart<\/i> 2015; 101: 101\u2013106.","DOI":"10.1136\/heartjnl-2014-306093"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, et al. Type-II myocardial infarction--patient characteristics, management and outcomes. <i>PLoS One<\/i> 2014; 9: e84285.","DOI":"10.1371\/journal.pone.0084285"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Meigher S, Thode HC, Peacock WF, Bock JL, Gruberg L, Singer AJ. Causes of elevated cardiac troponins in the emergency department and their associated mortality. <i>Acad Emerg Med<\/i> 2016; 23: 1267\u20131273.","DOI":"10.1111\/acem.13033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Smith SW, Pearce LA, Murakami MM, Apple FS. 102: Diagnosis of type I versus type II myocardial infarction in emergency department patients with ischemic symptoms (abstract). <i>Ann Emerg Med<\/i> 2011; 58: S211\u2013S212.","DOI":"10.1016\/j.annemergmed.2011.06.129"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. <i>Am J Cardiol<\/i> 2009; 104: 9\u201313.","DOI":"10.1016\/j.amjcard.2009.03.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, et al. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. <i>Circulation<\/i> 2009; 119: 2758\u20132764.","DOI":"10.1161\/CIRCULATIONAHA.108.833665"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, et al. Long term outcomes in patients with type 2 myocardial infarction and myocardial injury. <i>Circulation<\/i>, doi:10.1161\/CIRCULATIONAHA.117.031806.","DOI":"10.1161\/CIRCULATIONAHA.117.031806"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Ambrose JA, Loures-Vale A, Javed U, Buhari CF, Aftab W. Angiographic correlates in type 1 and 2 MI by the universal definition. <i>JACC Cardiovasc Imaging<\/i> 2012; 5: 463\u2013464.","DOI":"10.1016\/j.jcmg.2011.12.016"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-1399\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T15:35:18Z","timestamp":1603640118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-1399\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-1399","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}